The report, released at the World Hepatitis Summit, highlights that despite better tools for diagnosis and treatment, and decreasing product prices, testing and treatment coverage rates have stalled.
According to a research team co-led by a Cornell University astronomer, current state-of-the-art instrumentation being sent to Mars to collect and analyze evidence of life might not be sensitive enough to make accurate assessments.